PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 121 filers reported holding PRINCIPIA BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $589,895,000 | +255.9% | 5,896 | +112.7% | 0.00% | – |
| Q2 2020 | $165,738,000 | -86.3% | 2,772 | -86.4% | 0.00% | -100.0% |
| Q1 2020 | $1,209,808,000 | +933.0% | 20,374 | +852.9% | 0.00% | – |
| Q4 2019 | $117,120,000 | +119.8% | 2,138 | +13.3% | 0.00% | – |
| Q3 2019 | $53,289,000 | +117.6% | 1,887 | +155.7% | 0.00% | – |
| Q2 2019 | $24,494,000 | -39.3% | 738 | -37.8% | 0.00% | – |
| Q1 2019 | $40,358,000 | – | 1,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 401,046 | $23,814,000 | 13.70% |
| BVF INC/IL | 1,583,595 | $94,034,000 | 8.76% |
| Sofinnova Investments, Inc. | 1,417,258 | $84,157,000 | 7.78% |
| New Leaf Venture Partners, L.L.C. | 422,214 | $25,071,000 | 7.50% |
| Cormorant Asset Management, LP | 2,100,000 | $124,698,000 | 5.79% |
| Redmile Group, LLC | 2,261,088 | $134,263,000 | 3.76% |
| Consonance Capital Management LP | 689,718 | $40,955,000 | 3.05% |
| EAM Global Investors LLC | 43,369 | $2,575,000 | 1.51% |
| EAM Investors, LLC | 61,831 | $3,672,000 | 1.14% |
| Woodline Partners LP | 242,776 | $14,416,000 | 1.03% |